or a fall in LH; SHBG levels also remained elevated.
We suggest that since the plasma aestradiol level was only moderately raised it is unlikely that increased (estrogen production has stimulated the increased hepatic SHBG production; indeed, this rise in astradiol may be a consequence of the elevated SHBG, since aestradiol as well as testosterone binds to this protein. Thyrotoxicosis is associated with elevated SHBG accompanied by high total and bound testosterone and increased plasma LH levels (Crepy et al. 1967 , Ruder et al. 1971 ; this cause has been excluded in our patient. We suggest, however, that an increase in hepatic SHBG production following an attack ofjaundice may be the primary endocrine abnormality in our patient. Increased SHBG production would result in a fall in free testosterone and this would stimulate increased LH production with consequent Leydig cell stimulation. This would cause increased androgen production until the free testosterone level (monitored by the hypothalamus) returned to normal.
The suggested sequence of events in this patient parallels that seen in experimental hyperthyroidism induced in normal men by triiodothyronine administration, where a progressive rise in SHBG was accompanied by a marked elevation in bound testosterone and an increase in serum LH levels (Ruder et al. 1971) . The following cases were also presented: Large doses of ACTH given over a period of time will suppress the release of further endogenous ACTH in conditions of stress (Plager & Cushman 1962) . This effect is thought to occur in the brain and not in the pituitary gland and to be a direct action of ACTH rather than a result of the feedback action of the corticoids released from the adrenal glands (Penn & Sadow 1972) .
In our experiments, groups of male Wistar rats were given tetracosactrin (Cortrosyn) subcutaneously at 12 noon each day for 20 days. One group was given 0.05 pgg/100 g body weight per day and another group 0.5 pg/100 g body weight per day. Control animals were given an equivalent volume of saline subcutaneously each day for the same period.
The smaller dose caused a daily elevation of plasma corticosterone which was similar to that produced by a mild stress, the larger dose being comparable to a severe stress. The functional activity of the hypothalamo-pituitary-adrenal (HPA) system was assessed in both groups of test and control animals 24 h after the last treatment by submitting the animals to a standard ether stress. In the rats treated with the larger dose of ACTH the HPA system was depressed, releasing less corticosterone into the plasma when challenged with ether than the control animals. This suppression was due to the failure of the hypothalamo-pituitary complex of the HPA system since, after a small single test dose of ACTH, the adrenals of the animals treated with the prolonged high dose produced a similar rise in plasma corticosterone to that of the control animals. However, in the rats treated with the prolonged small dose of ACIH, the whole HPA system appeared to be functionally intact, as shown by the same tests as before (Fig 1) . Further, when the adrenals of the rats treated with the small dose were removed, quartered and incubated in vitro, the basal corticosterone production rate per unit weight of adrenal tissue was increased by approximately 65 % over the saline control animals as shown in Fig 2. The resting level of plasma corticosterone is always significantly higher in the animals treated with the small dose of ACTH than in the animals treated with saline or those with the high dose of ACTH. However, the basal corticosterone production rate is greatly increased due to the prolonged action of corticotrophin on the adrenal gland. Acs et al. (1967) studied the effect of long-term corticotrophin treatment on corticosteroid binding capacity of transcortin and found that ACTH given over a long period depresses the plasma transcortin concentration. Although in the present study transcortin levels were not measured, it might be tentatively suggested that the transcortin levels are not affected by the small dose of prolonged ACTH but are depressed by the high dose of prolonged ACTH, even in the presence of a high corticosterone production rate.
From these preliminary studies it is suggested that it may be possible to avoid hypothalamopituitary impairment and transcortin deficit in patients treated with prolonged intermittent ACTH and yet maintain the required improvement in the patient's endogenous steroid production by reducing the dose of ACTH given daily. There may be a certain critical dose margin above which hypothalamo-pituitary suppression occurs and below which there is an effect on the adrenal steroid production alone.
Plasma (Estrogen and Luteinng Hormone Concentrations in Thyrotoxic Menstrual Disturbance by EQ Akande mB mRcoG and T D R Hockaday DPhil FRCP (Radcliffe Infirmary, Oxford)
The interaction between the thyroid gland and the hypothalamo-pituitary-gonadal axis is poorly understood. Plasma luteiEtizing hormone levels are raised in female thyrotoxics (Akande & Hockaday 1972) but the relationship between luteinizing hormone (LH) and estrogen levels in these patients has not been elucidated.
Materials and Methods
Six female thyrotoxic patients in the reproductive age were studied as outpatients. They kindly agreed for blood samples to be collected daily at a constant time of day for 28 days before commencement of therapy. Plasma was separated within one hour and kept frozen at -23°C until assayed. Plasma was similarly obtained from 6 volunteer euthyroid female controls with no history of menstrual abnormality. They were of comparable age and parity to the patients.
Plasmacestrogens Weremeasured by the dextrancoated charcoal radioimmunoassay method described by Hotchkiss et al. (1971) without the chromatographic separation of cestradiol. The
